Caris Life Sciences® (NASDAQ: CAI) has published peer-reviewed clinical validation data in...
NEWS
FluoGuide Accelerates FG001 Commercialization Through Industry...
Copenhagen, Denmark—10 August 2025 – FluoGuide A/S has released highlights from its live-recorded...
Sanofi’s rilzabrutinib earns orphan designation in the EU for...
The European Medicines Agency (EMA) has granted orphan drug designation to rilzabrutinib, Sanofi’s...
Bayer Foundation and United Nations Capital Development Fund...
Bayer Foundation and the United Nations Capital Development Fund (UNCDF) partner to launch the...

